Success after a century of failures: Inside Moderna and Merck’s cancer vaccine breakthrough

Stephane Bancel, chief executive of Moderna, was at a Lebanese restaurant celebrating a friend’s birthday late on Aug 13 when he got the call.An mRNA cancer vaccine the company had been developing with Merck had hit its mark – the first success of a therapeutic cancer vaccine in late-stage testing after more than 100 y

There have been several promising developments lately in cancer research and treatment, including a new drug approved by the FDA this week for advanced pancreatic cancer. William Brangham reports.

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough  Reuters

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

New research has round the mRNA vaccine could help boost the survival rate of cancer patients.